Definiumtherapeutics

Director, Tax

Hybrid. Posted 8 days ago

The role

You will develop and execute tax strategy as the company transitions to a commercial-stage company. You will oversee tax accounting, planning, and compliance while building infrastructure for commercial operations.

What you will do

  • Lead tax strategy and planning including financings, equity compensation, and strategic transactions
  • Own ASC 740 tax accounting for SEC reporting and audits
  • Oversee federal, state, local, and international compliance performed by external providers
  • Lead tax readiness for commercialization including state, local, sales, use, franchise, and nexus considerations
  • Manage tax attributes and credits including Section 382, NOL preservation, and R&D credit studies
  • Support business development, licensing, collaboration transactions, transfer pricing, and legal entity planning
  • Serve as principal liaison to external tax advisors
  • Partner with various departments to build scalable tax processes, policies, and documentation

Required qualifications

  • Minimum bachelor's degree in accounting, Finance, Tax, or a related field
  • CPA certification
  • Minimum 10 years of progressive tax experience
  • Strong knowledge of ASC 740 and U.S. corporate taxation
  • Experience supporting public company reporting and managing external tax service providers
  • Strong project management, organizational, and communication skills

Nice to have

  • Master's in Taxation (MST) or advanced tax credential
  • Big Four or national public accounting experience
  • Biotech, pharmaceutical, life sciences, or healthcare industry experience
  • Experience supporting organizations transitioning from development-stage to commercial operations
  • Experience with Section 382, NOL planning, R&D credits, multi-state taxation, equity compensation, and capital markets transactions

Benefits

  • health insurance
  • 401(k) with company match
  • flexible time off
  • additional wellness benefits and perks

About the company

Definium Therapeutics is a late-stage clinical biopharmaceutical company. It is headquartered in New York and trades on Nasdaq under the symbol DFTX.

Director, Tax at Definiumtherapeutics | JobZoey